Skip to main content
Ventripoint Diagnostics Ltd. logo

Ventripoint Diagnostics Ltd. — Investor Relations & Filings

Ticker · VPT LEI · 529900QV0P93LL6P2M57 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 256 across all filing types
Latest filing 2025-06-17 Transaction in Own Shar…
Country CA Canada
Listing TSXV VPT

About Ventripoint Diagnostics Ltd.

https://ventripoint.com/

Ventripoint Diagnostics Ltd. is a medical device company specializing in AI-driven cardiac imaging solutions. The company's patented technology, embodied in the VMS+ software, transforms standard 2D echocardiograms into high-fidelity 3D models of all four heart chambers. This process provides accurate, reproducible volumetric measurements and ejection fractions, offering diagnostic performance comparable to MRI but with the speed and cost-effectiveness of ultrasound. The VMS+ system is designed to aid in monitoring patients with heart conditions, delivering detailed heart analysis even when using imperfect images or on patients who cannot undergo MRI procedures, such as those with pacemakers.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Transaction in Own Shares Classification · 1% confidence The document is a corporate news release reporting the issuance of option grants under the Company’s Stock Option Plan and the exercise (i.e., share issuance) of those options. It is not a management discussion, earnings release, or regulatory filing announcement, but rather an announcement of transactions in the company’s own shares (option grants and exercises). Therefore it falls under “Transaction in Own Shares” (POS).
2025-06-17 English
News release - English.pdf
Transaction in Own Shares Classification · 1% confidence The document is a corporate news release detailing the grant and exercise of stock options under the company’s Stock Option Plan, including issuance dates, vesting terms, option exercises, proceeds and outstanding option balances. This is not a financial report or regulatory filing, but rather an announcement of the company’s own-share transactions (issuing options and resulting share exercises). Under our taxonomy, such corporate equity transactions fall under “Transaction in Own Shares” (Code: POS).
2025-06-17 English
Notice of the meeting and record date (amended) - English.pdf
Regulatory Filings Classification · 1% confidence The document is a formal notice sent by the transfer agent (Computershare) to Canadian securities regulators advising of the cancellation of the upcoming Annual Meeting of Security Holders. It is not the Annual Report, proxy solicitation materials (PSI) itself, or any financial/earnings report. Rather, it is an administrative regulatory filing (a notice to the authorities). Therefore, it falls under the fallback category “Regulatory Filings” (RNS).
2025-05-20 English
News release - English.pdf
Regulatory Filings Classification · 1% confidence The document is a corporate press release providing a narrative update on product development, regulatory approvals, business partnerships, sales and marketing initiatives, financing efforts, and inviting shareholders to a teleconference. There are no specific financial results (revenues, profits, EPS) to qualify as an Earnings Release (ER) or Interim/Quarterly Report (IR), nor is this a formal Management Discussion & Analysis (MDA) filing with required financial tables. It is not an investor presentation deck (IP), proxy materials, or related to board changes, dividends, or share transactions. Therefore, the content does not match any specific specialized category and fits best within the fallback “Regulatory Filings” category for general corporate announcements.
2025-04-10 English
News release - English.pdf
Board/Management Information Classification · 1% confidence The document is a press release announcing the appointment of a new senior executive (Nic Coutin) to oversee Clinical Affairs. It provides details on his background, the reporting structure, and quotes from the CEO. This fits the category of an announcement of changes in the company’s senior management rather than a financial report, dividend notice, or other filings. Therefore, it should be classified as Board/Management Information (MANG).
2025-04-08 English
Material change report - English.pdf
Capital/Financing Update Classification · 1% confidence The document is a Canadian Form 51-102F3 material change report disclosing an amendment (extension) of warrant terms. It is not an earnings release or AGM material but rather an update to a financing instrument and capital structure. Therefore it aligns with the “Capital/Financing Update” category (CAP).
2025-04-07 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.